CN113274470B - 一种治疗新型冠状病毒肺炎的中药组合物 - Google Patents
一种治疗新型冠状病毒肺炎的中药组合物 Download PDFInfo
- Publication number
- CN113274470B CN113274470B CN202010102403.2A CN202010102403A CN113274470B CN 113274470 B CN113274470 B CN 113274470B CN 202010102403 A CN202010102403 A CN 202010102403A CN 113274470 B CN113274470 B CN 113274470B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- decocting
- novel coronavirus
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 101
- 206010035664 Pneumonia Diseases 0.000 title claims abstract description 89
- 241000711573 Coronaviridae Species 0.000 title claims abstract description 75
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 210000000582 semen Anatomy 0.000 claims abstract description 56
- 238000002360 preparation method Methods 0.000 claims abstract description 44
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 20
- 239000010440 gypsum Substances 0.000 claims abstract description 20
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 17
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 17
- 241000218671 Ephedra Species 0.000 claims abstract description 17
- 235000020224 almond Nutrition 0.000 claims abstract description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 16
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 16
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 16
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 16
- 235000011477 liquorice Nutrition 0.000 claims abstract description 16
- 241001127714 Amomum Species 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 5
- 244000197580 Poria cocos Species 0.000 claims abstract description 5
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 5
- 240000004980 Rheum officinale Species 0.000 claims abstract description 5
- 235000006533 astragalus Nutrition 0.000 claims abstract description 5
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 42
- 241001673966 Magnolia officinalis Species 0.000 claims description 36
- 239000009636 Huang Qi Substances 0.000 claims description 27
- 238000002156 mixing Methods 0.000 claims description 27
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 25
- 241001529821 Agastache Species 0.000 claims description 24
- 238000001035 drying Methods 0.000 claims description 24
- 238000010438 heat treatment Methods 0.000 claims description 24
- 239000002671 adjuvant Substances 0.000 claims description 22
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 22
- 239000008187 granular material Substances 0.000 claims description 22
- 239000003826 tablet Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 239000000341 volatile oil Substances 0.000 claims description 18
- 238000002791 soaking Methods 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 14
- 241000219061 Rheum Species 0.000 claims description 12
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 12
- 241000132012 Atractylodes Species 0.000 claims description 11
- 241000801118 Lepidium Species 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 241001346334 Amomum tsao-ko Species 0.000 claims description 4
- 241001573366 Astragalus membranaceus Species 0.000 claims description 4
- 240000002505 Pogostemon cablin Species 0.000 claims description 4
- 235000011751 Pogostemon cablin Nutrition 0.000 claims description 4
- 238000000465 moulding Methods 0.000 claims 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 35
- 208000024891 symptom Diseases 0.000 description 34
- 206010011224 Cough Diseases 0.000 description 14
- 206010012735 Diarrhoea Diseases 0.000 description 13
- 241001106477 Paeoniaceae Species 0.000 description 13
- 206010037660 Pyrexia Diseases 0.000 description 13
- 238000003745 diagnosis Methods 0.000 description 11
- 206010013781 dry mouth Diseases 0.000 description 10
- 230000008673 vomiting Effects 0.000 description 10
- 208000006083 Hypokinesia Diseases 0.000 description 9
- 206010047700 Vomiting Diseases 0.000 description 9
- 229940107666 astragalus root Drugs 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 206010008479 Chest Pain Diseases 0.000 description 6
- 208000001528 Coronaviridae Infections Diseases 0.000 description 6
- 208000000059 Dyspnea Diseases 0.000 description 6
- 206010013975 Dyspnoeas Diseases 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229940126680 traditional chinese medicines Drugs 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010028813 Nausea Diseases 0.000 description 4
- 230000006838 adverse reaction Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000008693 nausea Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 241001678559 COVID-19 virus Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 235000021152 breakfast Nutrition 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 229940093181 glucose injection Drugs 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- 108700005077 Viral Genes Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- OFFWOVJBSQMVPI-RMLGOCCBSA-N Kaletra Chemical compound N1([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)COC=2C(=CC=CC=2C)C)CC=2C=CC=CC=2)CCCNC1=O.N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 OFFWOVJBSQMVPI-RMLGOCCBSA-N 0.000 description 1
- 206010027417 Metabolic acidosis Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000071 effect on fever Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940113983 lopinavir / ritonavir Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000013185 thoracic computed tomography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Abstract
Description
组别 | 咳嗽 | 乏力 | 口干 | 腹泻呕吐 |
中药组 | 57.14% | 71.43% | 71.43% | 57.14% |
西药组 | 20% | 20% | 40% | 40% |
组别 | 天数 |
中药组 | 8.71 |
西药组 | 12.8 |
症状 | 例数 | 有效 | 无效 | 有效率 |
发热 | 29 | 21 | 8 | 72.41% |
咳嗽 | 20 | 7 | 13 | 35% |
胸闷 | 18 | 7 | 11 | 38.89% |
头痛 | 12 | 6 | 6 | 50% |
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010102403.2A CN113274470B (zh) | 2020-02-19 | 2020-02-19 | 一种治疗新型冠状病毒肺炎的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010102403.2A CN113274470B (zh) | 2020-02-19 | 2020-02-19 | 一种治疗新型冠状病毒肺炎的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113274470A CN113274470A (zh) | 2021-08-20 |
CN113274470B true CN113274470B (zh) | 2022-08-05 |
Family
ID=77275095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010102403.2A Active CN113274470B (zh) | 2020-02-19 | 2020-02-19 | 一种治疗新型冠状病毒肺炎的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113274470B (zh) |
-
2020
- 2020-02-19 CN CN202010102403.2A patent/CN113274470B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN113274470A (zh) | 2021-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111671880B (zh) | 用于治疗冠状病毒肺炎发热的中药制剂 | |
CN112353855A (zh) | 中药组合物在制备辅助治疗新型冠状病毒肺炎的药物中的应用 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN111249390A (zh) | 一种翘芪复方制剂及其制备方法和用途 | |
Wu et al. | Analysis on oral medication rules of traditional Chinese medicine prescriptions for prevention of COVID-19 | |
CN101664536B (zh) | 一种抗肿瘤的中药组合物 | |
CN104225319A (zh) | 一种治疗急性肾衰竭的中药制剂 | |
CN106138668A (zh) | 一种治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN113274470B (zh) | 一种治疗新型冠状病毒肺炎的中药组合物 | |
CN111671868B (zh) | 用于治疗轻症的新型冠状病毒肺炎失眠的中药组合物 | |
CN111228367B (zh) | 一种治疗小儿过敏性紫癜的中药外用洗剂及其制备方法 | |
CN102727765B (zh) | 一种阴阳双补治疗再生障碍性贫血的内服药物 | |
CN1199679C (zh) | 一种滋阴补肾、益气健脾的药物及制备方法 | |
CN1123354C (zh) | 一种治疗肺心病的药物 | |
CN115869375B (zh) | 一种清热疏风的中药组合物及其制备方法和应用 | |
CN114732883B (zh) | 一种健脾益胃的中药组合物及其制备方法、应用 | |
TWI840312B (zh) | 一種中藥組合物及其用途 | |
CN115998824B (zh) | 一种祛湿解毒的中药组合物及其制备方法和应用 | |
CN111228366B (zh) | 治疗病毒性肺炎的中药组合物 | |
CN114569670B (zh) | 一种治疗儿童功能性便秘的中药组合物 | |
CN109908294B (zh) | 一种用于治疗支气管扩张症稳定期的药物组合物及其制备方法和用途 | |
CN104758346A (zh) | 一种治疗偏头痛的药物及其制备方法、制剂 | |
CN117085072A (zh) | 一种预防和/或治疗泌尿系结石的中药组合物及制备方法 | |
CN104491662A (zh) | 一种治疗麻疹初期的中药制剂 | |
CN104474184A (zh) | 一种治疗感冒后咳嗽的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211207 Address after: 528244 No. 69, Jinfeng Road, Lishui Town, Nanhai District, Foshan City, Guangdong Province Applicant after: GUANGDONG YIFANG PHARMACEUTICAL Co.,Ltd. Address before: 100700 Beijing City, Dongcheng District Dongzhimen Nanxiaojie No. 16 Applicant before: CHINA ACADEMY OF CHINESE MEDICAL SCIENCES |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20210820 Assignee: SINOPHARM GROUP DEZHONG (FOSHAN) PHARMACEUTICAL Co.,Ltd. Assignor: GUANGDONG YIFANG PHARMACEUTICAL Co.,Ltd. Contract record no.: X2022980027259 Denomination of invention: A Chinese medicine composition for the treatment of novel coronavirus pneumonia Granted publication date: 20220805 License type: Common License Record date: 20230103 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20210820 Assignee: Shandong Zhongping Pharmaceutical Co.,Ltd. Assignor: GUANGDONG YIFANG PHARMACEUTICAL Co.,Ltd. Contract record no.: X2023980030277 Denomination of invention: A Chinese medicine composition for the treatment of novel coronavirus pneumonia Granted publication date: 20220805 License type: Common License Record date: 20230110 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20210820 Assignee: LONGXI YIFANG PHARMACEUTICAL CO.,LTD. Assignor: GUANGDONG YIFANG PHARMACEUTICAL Co.,Ltd. Contract record no.: X2023980030956 Denomination of invention: A Chinese medicine composition for the treatment of novel coronavirus pneumonia Granted publication date: 20220805 License type: Common License Record date: 20230116 |